Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation

被引:42
|
作者
Aldred, MJ
Talacko, AA
Savarirayan, R
Murdolo, V
Mills, AE
Radden, BG
Alimov, A
Villablanca, A
Larsson, C
机构
[1] Dorevitch Pathol, Heidelberg, Vic 3084, Australia
[2] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia
[3] Bendigo Hosp, Dept Anat Pathol, Bendigo, Australia
[4] Karolinska Univ Hosp, Dept Mol Med, Stockholm, Sweden
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2006年 / 101卷 / 02期
关键词
D O I
10.1016/j.tripleo.2005.06.01
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an important diagnosis because of the possible involvement of other family members and risk of malignant disease. We report clinical and genetic studies in a previously undocumented Australian family with HPT-JT. The proband and his sister presented with bilateral or recurrent mandibular radiolucencies diagnosed histopathologically as cemento-ossifying fibromas. Mutation screening of the recently identified disease gene HRPT2 was performed by direct sequencing in 3 affected members. This revealed a novel mutation in exon 1 of HRPT2 (nt 20AGGACG -> GGGAG), which is predicted to inactivate the parafibromin protein through protein truncation and premature termination of translation. The terminology used for the jaw lesions in this syndrome warrants review to become more consistent. Cemento-ossifying fibroma is the preferred term to better reflect the pathologies found in most individuals and families,and to emphasize the significance of the jaw lesions in the diagnosis of the syndrome.
引用
收藏
页码:214 / 220
页数:7
相关论文
共 50 条
  • [1] HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome
    Wang, PF
    Tan, MH
    Zhang, C
    Morreau, H
    Teh, BT
    HORMONE AND METABOLIC RESEARCH, 2005, 37 (06) : 380 - 383
  • [2] Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome
    Simonds, WF
    Robbins, CM
    Agarwal, SK
    Hendy, GN
    Carpten, JD
    Marx, SJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 96 - 102
  • [3] HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
    Carpten, JD
    Robbins, CM
    Villablanca, A
    Forsberg, L
    Presciuttini, S
    Bailey-Wilson, J
    Simonds, WF
    Gillanders, EM
    Kennedy, AM
    Chen, JD
    Agarwal, SK
    Sood, R
    Jones, MP
    Moses, TY
    Haven, C
    Petillo, D
    Leotlela, PD
    Harding, B
    Cameron, D
    Pannett, AA
    Höög, A
    Heath, H
    James-Newton, LA
    Robinson, B
    Zarbo, RJ
    Cavaco, BM
    Wassif, W
    Perrier, ND
    Rosen, IB
    Kristoffersson, U
    Turnpenny, PD
    Farnebo, LO
    Besser, GM
    Jackson, CE
    Morreau, H
    Trent, JM
    Thakker, RV
    Marx, SJ
    Teh, BT
    Larsson, C
    Hobbs, MR
    NATURE GENETICS, 2002, 32 (04) : 676 - 680
  • [4] Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene
    Cavaco, BM
    Guerra, L
    Bradley, KJ
    Carvalho, D
    Harding, B
    Oliveira, A
    Santos, MA
    Sobrinho, LG
    Thakker, RV
    Leite, V
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) : 1747 - 1752
  • [5] Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2
    Hobbs, MR
    Rosen, IB
    Jackson, CE
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (05) : 1376 - 1377
  • [6] A novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome
    Moon, SD
    Park, JH
    Kim, EM
    Kim, JH
    Han, JH
    Yoo, SJ
    Yoon, KH
    Kang, MI
    Lee, KW
    Son, HY
    Kang, SK
    Oh, SJ
    Kim, KM
    Yoon, SJK
    Park, JG
    Kim, IJ
    Kang, HC
    Hong, SW
    Kim, KR
    Cha, BY
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) : 878 - 883
  • [7] Insights into the pathogenesis of hyperparathyroidism-jaw tumor syndrome: Deciphering the role of Hrpt2 within bone development
    Droscha, Casey J.
    Cassandra, Diegel
    Williams, Bart O.
    CANCER RESEARCH, 2013, 73
  • [8] HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome
    J.D. Carpten
    C.M. Robbins
    A. Villablanca
    L. Forsberg
    S. Presciuttini
    J. Bailey-Wilson
    W.F. Simonds
    E.M. Gillanders
    A.M. Kennedy
    J.D. Chen
    S.K. Agarwal
    R. Sood
    M.P. Jones
    T.Y. Moses
    C. Haven
    D. Petillo
    P.D. Leotlela
    B. Harding
    D. Cameron
    A.A. Pannett
    A. Höög
    H. Heath
    L.A. James-Newton
    B. Robinson
    R.J. Zarbo
    B.M. Cavaco
    W. Wassif
    N.D. Perrier
    I.B. Rosen
    U. Kristoffersson
    P.D. Turnpenny
    L.-O. Farnebo
    G.M. Besser
    C.E. Jackson
    H. Morreau
    J.M. Trent
    R.V. Thakker
    S.J. Marx
    B.T. Teh
    C. Larsson
    M.R. Hobbs
    Nature Genetics, 2002, 32 : 676 - 680
  • [9] Expression and subcellular localization of the tumour suppressor parafibromin, encoded by the hyperparathyroidism-jaw tumour syndrome gene HRPT2
    Villablanca, A
    Yakoleva, T
    Juhlin, C
    Larsson, C
    Höög, A
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) : 717 - 717
  • [10] Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression
    Geoffrey E Woodard
    Ling Lin
    Jian-Hua Zhang
    Sunita K Agarwal
    Stephen J Marx
    William F Simonds
    Oncogene, 2005, 24 : 1272 - 1276